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Summary
Background Intimate partner violence (IPV) is associated with HIV infection. We aimed to assess whether provision 
of a combination of IPV prevention and HIV services would reduce IPV and HIV incidence in individuals enrolled in 
the Rakai Community Cohort Study (RCCS), Rakai, Uganda.
Methods We used pre-existing clusters of communities randomised as part of a previous family planning trial in this 
cohort. Four intervention group clusters from the previous trial were provided standard of care HIV services plus a 
community-level mobilisation intervention to change attitudes, social norms, and behaviours related to IPV, and a 
screening and brief intervention to promote safe HIV disclosure and risk reduction in women seeking HIV 
counselling and testing services (the Safe Homes and Respect for Everyone [SHARE] Project). Seven control group 
clusters (including two intervention groups from the original trial) received only standard of care HIV services. 
Investigators for the RCCS did a baseline survey between February, 2005, and June, 2006, and two follow-up surveys 
between August, 2006, and April, 2008, and June, 2008, and December, 2009. Our primary endpoints were self-
reported experience and perpetration of past year IPV (emotional, physical, and sexual) and laboratory-based diagnosis 
of HIV incidence in the study population. We used Poisson multivariable regression to estimate adjusted prevalence 
risk ratios (aPRR) of IPV, and adjusted incidence rate ratios (aIRR) of HIV acquisition. This study was registered with 
ClinicalTrials.gov, number NCT02050763.
Findings Between Feb 15, 2005, and June 30, 2006, we enrolled 11 448 individuals aged 15–49 years. 5337 individuals 
(in four intervention clusters) were allocated into the SHARE plus HIV services group and 6111 individuals (in seven 
control clusters) were allocated into the HIV services only group. Compared with control groups, individuals in the 
SHARE intervention groups had fewer self-reports of past-year physical IPV (346 [16%] of 2127 responders in control 
groups vs 217 [12%] of 1812 responders in intervention groups; aPRR 0·79, 95% CI 0·67–0·92) and sexual IPV 
(261 [13%] of 2038 vs 167 [10%] of 1737; 0·80, 0·67–0·97). Incidence of emotional IPV did not diﬀ er (409 [20%] of 
2039 vs 311 [18%] of 1737; 0·91, 0·79–1·04). SHARE had no eﬀ ect on male-reported IPV perpetration. At follow-up 2 
(after about 35 months) the intervention was associated with a reduction in HIV incidence (1·15 cases per 100 person-
years in control vs 0·87 cases per 100 person-years in intervention group; aIRR 0·67, 95% CI 0·46–0·97, p=0·0362).
Interpretation SHARE could reduce some forms of IPV towards women and overall HIV incidence, possibly through 
a reduction in forced sex and increased disclosure of HIV results. Findings from this study should inform future 
work toward HIV prevention, treatment, and care, and SHARE’s ecological approach could be adopted, at least partly, 
as a standard of care for other HIV programmes in sub-Saharan Africa.
Funding Bill & Melinda Gates Foundation, US National Institutes of Health, WHO, President’s Emergency Plan for 
AIDS Relief, Fogarty International Center.
Copyright © Wagman et al. Open Access article distributed under the terms of CC BY-NC-ND.
Introduction
The relation between intimate partner violence (IPV), HIV, 
and other sexually transmitted infections1–3 is 
bidirectional.2,4 Several pathways might explain the links 
between IPV and HIV infection. Forced sex might increase 
risk of direct transmission of HIV.1,3,5 Gender inequalities 
are key drivers of both IPV and HIV, and they mediate the 
relation between abuse and HIV transmission.1–3,5 Social 
norms that give men power over women increase the risk 
of violence against women and reduce women and girls’ 
ability to negotiate safe and consensual sex and seek 
protection from abuse.1,5 In addition, women who 
experience IPV and men who perpetrate IPV have a 
clustering of factors that increase their risk of HIV 
acquisition. Compared with women who are not exposed 
to abuse, those who have experienced lifetime IPV are 
more likely to report concurrent sex partners, problematic 
alcohol and substance use, transactional sex, and low or 
inconsistent condom use.1,5,6–8 Norms related to masculinity 
often encourage men to practise more risky sex. Evidence 
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suggests that male perpetrators of abuse are more likely to 
be infected with HIV or other sexually transmitted 
infections, engage the services of female sex workers, 
perpetrate non-IPV sexual assault, and (like women who 
have been abused) report concurrent sex partners, 
problematic alcohol and substance use, and low or 
inconsistent condom use.1,8–10 HIV-positive status and 
disclosure might increase risk of IPV, and fear of violence 
can prevent women from learning and sharing their HIV 
status and from accessing treatment.4,5,11
Several IPV and HIV prevention studies have been done 
in sub-Saharan Africa—the region most aﬀ ected by HIV/
AIDS and with some of the highest rates of IPV.12,13 
However, no intervention has successfully reduced both 
IPV and HIV.14 Two cluster-randomised trials in South 
Africa, where IPV has been found to increase risk of HIV 
infection,15 assessed the eﬀ ect of interventions that target 
gender norms and gender-based violence on HIV 
incidence. The Stepping Stones intervention was 
associated with a 33% reduction in incidence of herpes 
simplex virus type 2, reduced violence perpetration, and 
lower frequency of some risky behaviours, but did not 
aﬀ ect HIV incidence.16 The Intervention with Microﬁ nance 
for AIDS and Gender Equity (IMAGE) study reduced IPV 
incidence by 55%, increased HIV testing uptake, and 
reduced HIV risk behaviours in young women,17 but did 
not aﬀ ect the rate of unprotected sex with non-spousal 
partners or HIV incidence.18 Most recently, the SASA! 
study assessed the community-level eﬀ ect of a gender-
focused structured IPV and HIV prevention intervention 
in urban Uganda. Exposure to SASA! was associated with 
signiﬁ cant reductions in social acceptability of IPV in 
women and sexual concurrency in men. The programme 
was associated with decreases in physical and sexual IPV 
in women, but these reductions were not signiﬁ cant and 
the trial did not report an HIV outcome.19 Although these 
ﬁ ndings suggest that integrated gender equality and HIV 
training interventions oﬀ er potential synergies, they show 
the need for innovative strategies to reduce both HIV 
incidence and IPV.
The Safe Homes and Respect for Everyone (SHARE) 
Project aimed to reduce physical and sexual IPV and HIV 
incidence. SHARE uses two main approaches: 
community-based mobilisation to change attitudes and 
social norms that contribute to IPV and HIV risk, and a 
screening and brief intervention to reduce HIV-disclosure-
related violence and sexual risk in women seeking HIV 
counselling and testing (ﬁ gure 1). We aimed to assess the 
eﬀ ect on past-year IPV against women, HIV incidence, 
and certain sexual risk behaviours of adding SHARE into 
ongoing HIV treatment and prevention activities of the 
Rakai Health Sciences Programme (RHSP).
Methods
Study design and participants
We did this comparative study in Rakai, Uganda, where 
IPV has been associated with HIV incidence.20 Rakai is a 
traditionally patriarchal society,21 with high HIV 
prevalence (12%) and incidence (1·2 per 100 person-
years)22 and relatively high rates of IPV against women 
(29% in the past year).20 The study was nested in the 
Rakai Community Cohort Study (RCCS), described in 
detail elsewhere.23 RCCS is an open, community-based 
cohort study that takes a census, interviews, and 
serological surveys every 12–18 months in about 
50 communities that are aggregated into 11 study 
clusters—originally selected to be relatively homo-
geneous.24 The 50 RCCS communities represent 7% of 
the 720 communities in the Rakai district. The 11 clusters 
are made up of two to eight communities each and the 
mean number of households per cluster is 809.22 Before 
the RCCS survey, investigators do a census in all 
residents (about 28 000 individuals) in roughly 
9000 households. The investigators generate lists of 
eligible RCCS participants (ie, resident individuals aged 
15–49 years) and contact each of the individuals and ask 
for their consent to enrol in RCCS. Surveys are done in 
person in the local language of Luganda with structured 
questionnaires to obtain sociodemographic, behavioural, 
health, and care-seeking data. Sexual network 
information is obtained for up to four partners in the 
previous year. About 90% of eligible participants have 
consented to an interview at each survey.22,23 Blood 
samples are taken for HIV detection. About 98% of 
participants provide a sample for HIV testing, and are 
oﬀ ered free HIV counselling and testing and risk 
reduction education; about 80% request their results 
and counselling.25 Those individuals who test positive 
are referred for care and treatment,25,26 including with 
HAART.
Our inclusion criteria were individuals aged 
15–49 years who completed an RCCS interview and 
provided blood for HIV testing at baseline (Feb 15, 2005, 
to June 30, 2006) and at two follow-up visits in 
Aug 30, 2006, to April 24, 2008, and June 6, 2008, to 
Dec 7, 2009. The baseline survey was done before the 
intervention was given, and follow-up appointments 
were staggered so that each intervention cluster had 
roughly the same duration of exposure to the SHARE 
intervention. The ﬁ rst follow-up began about 16 months 
after the baseline and spanned the intervention scale-up 
and full implementation phases. The ﬁ nal follow-up 
began about 35 months after baseline. The SHARE 
intervention was planned to last about 4 years, 1 year for 
each phase (after the community assessment): raising 
awareness, building networks, integrating action, and 
consolidating eﬀ orts.
Surveys were done in private by same-sex interviewers 
who were trained by certiﬁ ed Rakai Health Science 
Program ethics and clinical practice trainers in research 
ethics and good clinical practice. All interviewers were 
trained using WHO’s guidelines for safe and ethical 
research on domestic violence,27 including IPV 
sensitisation, and how to minimise possible distress 
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related to research on violence or sensitive topics. All 
women who reported IPV and requested assistance were 
actively referred to an RHSP counsellor trained to 
provide basic psychosocial support and risk reduction 
skills to victims. No services were made available to 
perpetrators of violence. The study was approved by the 
Western Institutional Review Board (Olympia, WA, 
USA), WHO’s Ethics Review Committee, the Uganda 
Virus Research Institute’s Scientiﬁ c and Ethics 
Committee, and the Ugandan National Council of 
Science and Technology. All individuals gave written 
consent.
Cluster selection
Our study was built on a cluster-randomised trial done 
between April 6, 1999, and Aug 1, 2003, to assess the 
eﬀ ect of enhanced family planning outreach in Rakai.28 
In that trial, ﬁ ve clusters were randomly assigned to 
receive standard family planning services (control) and 
six clusters were randomly assigned to receive a family 
planning intervention. We used these clusters in our 
trial. Because of funding limitations for our trial, only 
four intervention clusters were randomly chosen (with a 
computer-generated randomisation programme) from 
the original six family planning intervention clusters to 
Figure 1: Logic model of the SHARE Project
SHARE=Safe Homes and Respect for Everyone. IPV=intimate partner violence. CAC=community activism course. CCA=community counselling aides. RHSP=Rakai Health Sciences Program. HCT=HIV 
counselling and testing. ART=antiretroviral therapy.
Leaders, oﬃcials, and policy makers informed about IPV and 
women’s rights and given opportunity to discuss and make 
decisions
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Public policies made to prevent IPV. More resources allocated to 
screening, treating, and preventing violence
Police, social welfare oﬃcers, health-care providers, teachers, local 
and religious leaders, SHARE staﬀ, and volunteers completed CAC 
on IPV prevention
Capacity
building
Leaders and key individuals or groups have knowledge about IPV, its 
causes and consequences, understand human rights, and have skills to 
advocate for women’s rights 
Community volunteers (n=40) appointed and trained as SHARE 
ambassadors; IPV watch groups and community action groups 
formed; village meetings and forums held
Community
activism
Community members change their own behaviours (to prevent IPV) 
and attitudes (to reject IPV as acceptable and hold women to the same 
standard as men)
Booklets, brochures, posters, story cards, and other materials 
developed and disseminatedLearningmaterials
Community members have knowledge about IPV and why it is a 
public health concern
Special events
Ideas about IPV prevention and gender norms have been publicly 
discussed and explored throughout community
Community-based fairs, marches, campaigns, and poster shows; 
violence prevention newsletters created and disseminated to 
entire community
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Young people understand the importance of gender-equitable 
relationships and have eﬀective skills for talking openly about sex, 
reducing HIV risk, and resolving of conﬂicts without violence
Men’s and boy’s 
programme
Boys and men understand how masculinity and female subordination 
aﬀect IPV.  Boys and men adopt non-violent approaches to problem 
solving, safe and consensual sex, and use alcohol responsibly
12 CCAs appointed, completed 3-part CAC and trained to oﬀer 
basic psychosocial support and make referralsCCAs
CCAs provide support to people experiencing IPV or HIV and catalyse 
referral process (to SHARE or RHSP-HIV counsellor) when necessary
HIV counselling
protocols
modified to
address IPV
Fewer cases of IPV experienced due to seeking or disclosing of HIV 
results. More women experiencing IPV able to mitigate risk factors for 
HIV infection
HCT and ART
counsellor
training
Counsellors understand IPV and rights; screen for, handle, and refer 
cases; discuss safe, mediated or non-disclosure of HIV results; and risk 
reduction
Support groups
for HIV-positive
women
HIV-positive women experiencing IPV had forum to discuss related 
issues in a supportive and non-judgmental environment  
12 peer groups formed for married, in and out of school young 
people of both sexes. Ten sessions held on communication, sex, love, 
HIV, safe sex, gender equality, and non-violent conﬂict resolution
Male leaders (n=48) trained using the CAC curriculum; ten lesson 
work plan for men and boys on IPV and alcohol reduction, IPV, 
and HIV risk
HCT counsellors trained to: screen women for IPV and handle or 
refer IPV cases; help HIV-positive women develop safe HIV disclosure 
plans; help abused women develop safe sex negotiation skills
HCT and ART counsellors completed CAC, and were trained to 
screen for and handle IPV, and do disclosure and risk assessments
14 HIV-positive women trained to facilitate support group 
meetings. Support groups conducted on clinic days for HIV-infected 
women experiencing violence
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take advantage of existing infrastructure for community 
health workers. All ﬁ ve control clusters from the original 
family planning study plus the remaining two family 
planning intervention clusters were included in the 
seven control clusters for our trial. Investigators were not 
masked to study group assignment.
Procedures
We oﬀ ered all individuals (control and intervention 
clusters) routine HIV prevention and treatment services, 
including free HIV testing, pretest and post-test 
counselling through community-based counsellors, and 
referral for care25 (panel 1). Participants in the intervention 
group were exposed to the SHARE violence-reduction 
intervention and screening and a brief intervention to 
reduce IPV related to HIV disclosure and risk behaviours 
in women seeking HIV counselling and testing. SHARE29 
is an ecological framework to intervene against drivers of 
IPV and HIV transmission at the individual, relationship, 
and societal levels (ﬁ gure 1). SHARE was based on the 
stages of change theory,30 which is most commonly used 
at the individual-level but adapted for use in Rakai at the 
community-level by use of the Raising Voices Resource 
Guide for Organizations in East and Southern Africa.31 
SHARE involved ﬁ ve distinct phases and used ﬁ ve main 
strategies (panel 2).29
SHARE staﬀ  included three women and two men with 
tertiary education, training in HIV and psychosocial 
counselling, and ﬂ uency in English and Luganda 
language, who received 4 weeks of training on IPV 
awareness and prevention, provision of violence-related 
support, and ethical protection of participants. SHARE 
also appointed and trained 40 community volunteers and 
12 community counselling aides to work with core 
SHARE staﬀ  (appendix). Additionally, SHARE provided 
focused programmes for men, boys, and young people 
and integrated violence prevention into RHSP’s existing 
HIV counselling and testing and HAART programmes 
(appendix).
Outcomes
Our primary endpoints were self-reported experience and 
perpetration of past-year IPV (physical, emotional, and 
sexual) and laboratory-based diagnosis of HIV incidence 
in the study population. Sexual IPV was deﬁ ned as 
penetrative and non-penetrative sex, and other unwanted 
sexual acts. Abused women commonly experience more 
than one type of violence in Rakai,20 but we measured 
physical and sexual IPV separately to assess whether 
SHARE had a diﬀ erential eﬀ ect on these two outcomes. 
Our secondary endpoints were forced sex (deﬁ ned as 
unwanted, physically forced penetrative sex) and HIV risk 
behaviour and disclosure (respondent’s and primary 
partner’s) in the last year of the intervention. We used an 
adaptation of the conﬂ ict tactics scales32 to measure each 
Panel 1: Rakai Health Sciences Program’s routine HIV 
prevention and treatment services
Both groups were given Rakai Health Sciences Program’s 
routine HIV prevention and treatment services, which 
included the following items:
• Provision of free condoms
• Syndromic sexual transmitted infection treatment
• General medical care
• Prevention of mother-to-child HIV transmission
• HIV prevention and general health education
• HIV monitoring and treatment: people with HIV who 
accepted voluntary counselling and testing were referred 
for free CD4 cell count assessment and HIV care, including 
co-trimoxazole prophylaxis for opportunistic diseases, 
bednets for malaria prevention, clean water containers 
and hypochlorite for prevention of diarrhoea, and positive 
living education
• HAART: individuals were started on standard ﬁ rst-line 
ART when they reached WHO stage IV disease or had a 
CD4 cell count of lower than 250 cells per μL; individuals 
taking HAART were monitored via CD4 cell counts and 
HIV viral lo ads
Panel 2: Safe Homes and Respect for Everyone (SHARE) 
Intervention Structure and Strategy
Phase 1: Community assessment (2000–04)
This pre-intervention phase aimed to assess the magnitude, 
determinants, correlates, and outcomes of intimate partner 
violence (IPV), and to develop relationships with the 
community, hire and train SHARE staﬀ , and prepare for 
intervention rollout.
Phase 2: Raising awareness (2005–06)
Intervention rollout: aimed to introduce SHARE and 
stimulate dialogue on IPV, help people to deﬁ ne and 
understand it, and raise awareness about IPV’s negative 
consequences.
Phase 3: Building networks (2006–07)
Intervention scale-up aimed to prepare the community to 
change their attitudes about IPV and reduce their own violent 
behaviours.
Phase 4: Integrating action (2007–08)
Full intervention implementation; goal was to make actions 
against IPV part of everyday life and institutional policies 
and practices.
Phase 5: Consolidating eﬀ orts (2008–09)
This ﬁ nal, intervention wind-down phase aimed to transition 
SHARE staﬀ  members away from routine work in the 
intervention clusters while community members assumed 
the day-to-day tasks of the project. The goal was to ensure 
that the community could sustain the reduced levels of IPV 
through development of long-term action plans and local 
bylaws that continue prevention eﬀ orts.
See Online for appendix
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type of IPV (appendix). HIV risk behaviours were total 
number of sex partners, number of non-marital sex 
partners, alcohol use with last sex, and condom use, and 
disclosure of their HIV status in the past year (appendix).
HIV status was established from venous blood samples 
with two enzyme immunoassays (Vironostika HV-1 
[Organon Teknika, Charlotte, NC, USA] and Cambridge 
Biotech [Worcester, MA, USA]), with Western blot 
(bioMérieux VITEK, St Louis, MO, USA) conﬁ rmation of 
discordant enzyme immunoassay results and all 
seroconversions. We analysed HIV incidence data during 
the SHARE trial to assess intervention eﬃ  cacy before the 
SHARE baseline (2004–05), pre-baseline similarity 
between study groups, and after the trial ended (2010–11) 
to assess postintervention sustainability of any eﬀ ects on 
HIV incidence.
We also obtained data for social and demographic 
characteristics, HAART use, and male circumcision. The 
SHARE trial coincided with the introduction of HAART 
in June, 2004, by the Government of Uganda, and the last 
year of follow-up of a male circumcision for HIV 
prevention trial33 (stopped in December, 2006) and 
provision of circumcision services thereafter. 
Circumcision status was assessed by questions asking 
men, “are you circumcised?” and women were asked “is/
was your husband/recent sexual partner circumcised?” 
Female reported circumcision status of male partners 
has been validated in this population.34 HAART uptake in 
both groups of the trial was measured at baseline and 
follow-up with a combination of RHSP HAART clinic 
data and self-reported data from the RCCS survey.
Statistical analysis
We postulated that exposure to SHARE would lead to a 
minimum 10% relative reduction of each type of violence 
in the intervention group, assuming an initial physical 
IPV prevalence of about 20% and sexual IPV prevalence 
of about 14·5%. Because the study was nested within the 
RCCS, the eﬀ ective sample size was established by 
enrolment into the cohort. For IPV outcomes, the study 
was powered on the basis of an approximate intervention 
group population of about 3500 individuals and a control 
population of roughly 11 100 people, giving the study 80% 
power to detect the hypothesised IPV reductions (two 
sided α=0·05). For the HIV incidence outcome (about 
1·2 per 100 person-years), we expected about 4753 person-
years of exposure in the intervention group and about 
16 969 person-years of exposure in the control group, and 
estimated 80% power (two sided α=0·05) to detect 36% 
lower HIV incidence in the intervention group compared 
with the control group. After selection of intervention 
clusters, sample sizes were higher for the intervention 
groups and lower for the control groups than we had 
initially anticipated, which had little eﬀ ect on the power 
of the study.
Social and demographic characteristics, circumcision 
status, IPV, risk behaviours, HIV prevalence, and 
HAART use were measured at baseline to assess 
comparability between study groups. Baseline diﬀ erences 
between groups were estimated using Pearson’s χ² and 
Fisher’s exact tests for diﬀ erences in proportions, and 
t-tests and Wilcoxon rank-sum tests for continuous 
variables. These outcomes and HIV incidence were 
assessed at follow-up to show diﬀ erences between study 
groups with an intention-to-treat approach in which all 
eligible participants with complete data were included in 
the analysis by study group, irrespective of crossovers or 
direct exposure to SHARE activities. Diﬀ erences in loss-
to-follow-up between the two groups were assessed by χ² 
tests. We established study retention on the basis of the 
number of participants interviewed at either of the two 
follow-up visits. We used two-tailed p values (p<0·05) for 
statistical inference.
We analysed all outcomes separately for men and 
women and for the ﬁ rst and second follow-up visits. Our 
analysis included respondents who attended both the ﬁ rst 
and second follow-up visits plus respondents who were 
not available in follow-up 1 but were then available in 
follow-up 2. We accounted for the cluster eﬀ ect by ﬁ tting a 
random-intercept model at the cluster level to test for 
potential within-cluster correlation. We analysed IPV and 
Figure 2: Study proﬁ le
*Four intervention clusters from the Rakai Community Cohort Study (RCCS) randomly chosen; two of these and 
ﬁ ve RCCS control clusters became the control populations. †People who could not be re-contacted were those who 
could not be contacted at the ﬁ rst follow-up but available at follow-up 2; those lost to follow-up were individuals 
who were not available at ﬁ rst follow-up and second follow-up.
11 clusters assessed for eligibility 
21 636 individuals assessed 
11 clusters eligible (n=11 448) for the 
 SHARE assessments
7 clusters (n=6111) allocated to control group* 4 clusters (n=5337) allocated to intervention group*
 432 could not be re-contacted†
1612 lost to follow-up 
 293 could not be re-contacted†
1269 lost to follow-up 
4067 completed follow-up 1 3775 completed follow-up 1
503 could not be re-contacted  813 could not be re-contacted 
3564 completed follow-up 2 and analysed 2962 completed follow-up 2 and analysed
10 188 excluded 
 2849 did not meet inclusion criteria 
 968 declined to participate 
 124 were incapacitated 
 6199 away (work/visiting/school) 
 48 parent or guardian not available 
  to consent for child
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secondary HIV risk behaviour outcomes as dichotomous 
variables. In view of the low correlation within clusters 
and diﬃ  culty of veriﬁ cation of the random eﬀ ects 
assumptions because of the small number of clusters 
(n=11), we ﬁ t generalised linear models for the main 
analysis. We used a modiﬁ ed Poisson multivariate 
regression that combines a log Poisson regression model 
with number of people as the oﬀ set, and robust variance 
estimation, allowing for an approximation to the log 
binomial model to estimate adjusted prevalence risk ratios 
(aPRRs) for the IPV and HIV risk behaviour outcomes.35 
We ﬁ tted a generalised linear model using a log link with 
the observed population as an oﬀ set and an assumed 
underlying Poisson distribution.
For analysis of HIV incidence, we calculated person-
years of exposure from baseline to the last negative HIV 
result when the person remained negative, or to the 
midpoint of the interval between the last negative and 
Women (n=6702) Men (n=4746)
Control (n=3544; 
53%)
Intervention 
(n=3158; 47%)
p value Control (n=2567; 
54%)
Intervention 
(n=2179; 46%)
p value
Age, years 0·0012 0·0343
15–19 374 (11%) 369 (12%) ·· 199 (8%) 225 (10%) ··
20–24 887 (25%) 766 (24%) ·· 484 (19%) 397 (18%) ··
25–29 956 (27%) 755 (24%) ·· 590 (23%) 474 (22%) ··
30–34 629 (18%) 538 (17%) ·· 503 (20%) 437 (20%) ··
≥35 698 (20%) 730 (23%) ·· 791 (31%) 646 (30%) ··
Religion 0·0949 0·4802
Christian 2948 (83%) 2621 (84%) ·· 2126 (83%) 1778 (82%) ··
Muslim 566 (16%) 481 (15%) ·· 421 (16%) 371 (17%) ··
Other or no religion 22 (1%) 34 (1%) ·· 19 (1%) 22 (1%) ··
Education level 0·0425 0·0110
None 523 (15%) 526 (17%) ·· 262 (10%) 222 (10%) ··
Primary 1981 (56%) 1769 (56%) ·· 1435 (57%) 1304 (60%) ··
Secondary or higher 1040 (30%) 863 (27%) ·· 870 (34%) 653 (30%) ··
Marital status 0·5109 0·0491
Never married 476 (13%) 456 (14%) ·· 575 (22%) 528 (24%) ··
Currently married or in union 2991 (84%) 2635 (83%) ·· 1949 (76%) 1596 (73%) ··
Previously married 77 (2%) 67 (2%) ·· 46 (2%) 55 (3%) ··
Circumcised participants (if men) or partners 
(if women)
1191 (34%) 1017 (32%) 0·2612 381 (20%) 376 (22%) 0·2501
Past-year IPV
Emotional 878 (25%) 772 (25%) 0·7574 771 (30%) 626 (29%) 0·2163
Physical 653 (18%) 523 (17%) 0·0451 316 (12%) 242 (11%) 0·1853
Sexual 580 (16%) 415 (13%) 0·0005 147 (6%) 92 (4%) 0·0153
Past-year forced sex 500 (14%) 357 (12%) 0·0001 101 (4%) 58 (3%) 0·0192
>1 sexual partners in past year 214 (6%) 157 (5%) 0·0621 1208 (47%) 914 (42%) 0·0001
Alcohol with sex (past year) 887 (25%) 821 (26%) 0·3654 943 (39%) 876 (40%) 0·2019
Number non-marital sex partners in past year 0·0561 0·0001
0 2516 (82%) 2268 (84%) ·· 1378 (54%) 1280 (59%) ··
1 483 (16%) 392 (15%) ·· 800 (31%) 608 (28%) ··
≥2 69 (2%) 42 (2%) ·· 389 (15%) 291 (13%) ··
Condom use in past year 0·7330 0·0911
Yes, always 316 (9%) 274 (9%) ·· 398 (16%) 378 (17%) ··
None or inconsistent 3228 (91%) 2884 (91%) ·· 2169 (85%) 1801 (83%) ··
Partner’s disclosure of HIV status (past year) 669 (19%) 481 (15%) 0·0001 544 (22%) 365 (17%) 0·0001
Self-disclosure of HIV status to partner 
(past year)
949 (27%) 764 (24%) 0·0210 647 (26%) 411 (19%) 0·0001
HIV prevalence* 448/3175 (14%) 343/2814 (12%) 0·0026 253/2896 (11%) 184/2789 (9%) 0·0288
HAART uptake* 49/448 (11%) 46/343 (13%) 0·2888 17/253 (7%) 19/184 (10%) 0·1758
Data are n (%), unless otherwise indicated. *Population size diﬀ ers due to availability of blood samples.
Table 1: Baseline characteristics and risk behaviours in past year
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ﬁ rst positive tests for seroconverters. HIV incidence was 
estimated per 100 person-years. We used Poisson 
multivariate regression models with robust variance 
estimation to estimate the adjusted incidence rate ratios 
(aIRR) of HIV acquisition between intervention to 
control groups. Our analysis was preplanned and did not 
adjust for multiple comparisons, but we do account for 
them in the interpretation.36 We used Stata/SE version 12 
for data analysis. This trial is registered with 
ClinicalTrials.gov, number NCT02050763.
Role of the funding source
The funders had no role in study design, data collection, 
data analysis, data interpretation, or writing of the report. 
The corresponding author had full access to all the data 
and had ﬁnal responsibility for the decision to submit for 
publication.
Results
Between Jan 17, 2005, and May 24, 2006, 21 636 individuals 
from 11 clusters were assessed for eligibility by the RCCS 
census team. We enrolled 11 448 men and women aged 
15–49 years: 6111 in the control group clusters and 5337 in 
the intervention group clusters (ﬁ gure 2). 8565 (75%) 
attended either round of follow-up (4499 [74%] in the 
control vs 4068 [76%] in the intervention; p=0·0012), 
consistent with average RCCS follow-up rates of about 
75% between successive visits.22,23 Across the entire trial, 
7842 (69%) participants were assessed at follow-up 
1 and 6526 (57%) participants at follow-up 2. Cumulative 
retention rates (ie, at follow-up 2) were higher in the 
control group (3564 [58%]) than in the intervention group 
(2962 [56%]; p=0·0031), and in women (3939 [59%]) than 
in men (2587 [55%]; p=0·0001). Because of the open 
nature of the cohort, loss to follow-up was mainly because 
participants could not be located. The study lasted 4 years 
and 7 months.
Baseline characteristics of the two study groups were 
broadly similar (table 1). There were more younger 
(age 15–19 years) and older (age 35 years and older) 
individuals in the intervention group than in the control 
group, and control group participants had higher levels of 
secondary (or more) education than had the intervention 
group. Physical and sexual IPV in women, forced sex, and 
HIV results disclosure were more common in the control 
group than in the intervention group at baseline. Baseline 
HIV prevalence was higher in the control (12%) than in the 
intervention group (9%) for both women and men (table 1).
Table 2 shows IPV outcomes by group. The proportions 
of women who experienced physical IPV, sexual IPV, and 
forced sex were signiﬁ cantly lower in the SHARE 
intervention group at the second follow-up than in the 
control group after adjustment for baseline IPV, age, 
education, and marital status (table 2). The intervention 
did not signiﬁ cantly reduce women’s experiences of 
emotional IPV (table 2). Men’s reports of emotional and 
physical IPV perpetration decreased over the course of the 
trial in both groups, but reported ﬁ nal IPV rates at follow-
up did not diﬀ er signiﬁ cantly (table 2).
Women’s reports of their own disclosure of HIV status 
and their partner’s disclosure of his HIV status were 
higher in the intervention than in the control group at 
second follow-up (table 3). Men in the intervention group 
more frequently reported their primary female partner’s 
disclosure of her HIV status, and their own disclosure of 
HIV status (table 3). HIV incidence for both sexes 
combined was lower in the intervention group than in 
the control group after adjustment (table 4). The 
intervention was associated with a signiﬁ cantly lower 
HIV incidence in men (p=0·0304) but did not diﬀ er in 
women (p=0·1020; table 4).
The appendix contains a table to show secular trends in 
HIV incidence rates by groups for the RCCS population 
during ﬁ ve consecutive RCCS survey intervals between 
2004 and 2011. The ﬁ rst interval (2004–05) was before 
study initiation. At baseline (2005–06), HIV incidence 
did not signiﬁ cantly diﬀ er between groups (1·05 per 
100 person-years). HIV incidence was lower in 
the intervention than in the control group during 
the intervention roll-out phase (2006–08), at the ﬁ rst 
Control Intervention  PRR (95% CI) aPRR*(95% CI)
Women
Experience of past-year emotional (verbal) abuse
Follow-up 1 498/2338 (21%) 495/2257 (22%) 1·03 (0·92–1·15) 1·02 (0·92–1·14)
Follow-up 2 409/2039 (20%) 311/1737 (18%) 0·89 (0·78–1·02) 0·91 (0·79–1·04)
Experience of past-year physical IPV
Follow-up 1 397/2426 (16%) 353/2342 (15%) 0·92 (0·81–1·05) 0·97 (0·85–1·11)
Follow-up 2 346/2127 (16%) 217/1812 (12%) 0·74 (0·63–0·86) 0·79 (0·67–0·92)
Experience of past-year sexual IPV
Follow-up 1 292/2337 (13%) 296/2257 (13%) 1·05 (0·90–1·22) 1·12 (0·96–1·31)
Follow-up 2 261/2038 (13%) 167/1737 (10%) 0·75 (0·62–0·90) 0·80 (0·67–0·97)
Experience of past-year forced sex
Follow-up 1 261/2337 (11%) 262/2257 (12%) 1·04 (0·88–1·22) 1·12 (0·95–1·32)
Follow-up 2 232/2038 (11%) 145/1737 (8%) 0·73 (0·60–0·89) 0·79 (0·65–0·96)
Men
Perpetration of past-year emotional (verbal) IPV
Follow-up 1 520/1586 (33%) 401/1367 (29%) 0·92 (0·80–0·99) 0·88 (0·78–0·98)
Follow-up 2 315/1407 (22%) 251/1104 (23%) 1·02 (0·88–1·18) 0·99 (0·85–1·16)
Perpetration of past-year physical IPV
Follow-up 1 185/1641 (11%) 132/1433 (9%) 0·82 (0·66–1·01) 0·80 (0·64–1·00)
Follow-up 2 124/1437 (9%) 99/1150 (9%) 1·00 (0·77–1·28) 1·00 (0·77–1·30)
Perpetration of past-year sexual IPV
Follow-up 1 73/1586 (5%) 56/1367 (4%) 0·89 (0·63–1·25) 0·90 (0·63–1·28)
Follow-up 2 53/1407 (4%) 30/1104 (3%) 0·72 (0·46–1·12) 0·81 (0·52–1·26)
Perpetration of past-year forced sex
Follow-up 1 47/1586 (3%) 38/1367 (3%) 0·94 (0·61–1·43) 1·00 (0·65–1·55)
Follow-up 2 39/1407 (3%) 24/1104 (2%) 0·78 (0·47–1·30) 0·85 (0·50–1·42)
Data are n/number who responded (%) unless otherwise stated. IPV=intimate partner violence. PRR=prevalence rate 
ratio. aPRR=adjusted prevalence rate ratio. *Eﬀ ects of intervention adjusted for baseline age, baseline education, baseline 
marital status, and baseline experience of IPV victimisation (women) or perpetration (men), according to type measured.
Table 2: Eﬀ ect of intervention on IPV outcomes
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follow-up interval (aIRR 0·60, 95% CI 0·42–0·84), and 
full implementation phase (2008–09) at the second 
follow-up interval (0·66, 0·49–0·90). During the scale-up 
and full implementation phases of the intervention 
(2006–09), HIV incidence decreased in the intervention 
group, compared with pre-baseline, and at follow-up 
intervals one and two. By contrast, incidence increased in 
the control group during these two follow-up intervals. 
However, during the post-SHARE follow-up (2010–11) 
incidence was similar between study groups, suggesting 
that the diﬀ erence in HIV incidence between groups was 
not sustained post-intervention.
Although baseline uptake of HAART was similar 
between groups (table 1), more women than men infected 
with HIV were taking HAART in both the control (49 
[11%] vs 17 [7%]) and intervention (46 [13%] vs 19 [10%]) 
clusters, which might have contributed to the larger 
decrease in HIV incidence in men at second follow-up. 
Men and women’s use of HAART increased over the 
course of the trial and remained similar at ﬁ nal follow-up 
for women in the control group at 34% (111 of 328) versus 
the intervention group at 32% (72 of 227; p=0·6009). In 
men, ﬁ nal follow-up HAART use in the control group 
was 24% (46 of 193) versus 33% (39 of 118, p=0·0768) in 
the intervention group. We noted no signiﬁ cant 
correlation within clusters for all IPV outcomes (r=0, 
p=1·0) and previous research established low within-
cluster correlation for HIV outcomes.24
Discussion
SHARE signiﬁ cantly reduced reports of women’s 
physical IPV, sexual IPV, and forced sex. However, male-
reported perpetration of IPV was not signiﬁ cantly 
aﬀ ected by the intervention and diﬀ erences in emotional 
IPV were not signiﬁ cant. SHARE was also associated 
with signiﬁ cant increases in disclosure of HIV status in 
men and women. Finally, SHARE was associated with a 
lower HIV incidence during the intervention period, but 
this reduction was not maintained after SHARE ended, 
suggesting that continued exposure to the intervention 
might be need to achieve a sustained eﬀ ect.
Reports of physical and sexual IPV victimisation from 
women were much more common than were reports of 
perpetration from men, as seen in other studies37 and 
consistent with ﬁ ndings from the SASA! trial in Uganda 
(panel 3).40 Although some of these diﬀ erences might be 
because of less eﬀ ective programming with men or 
diﬃ  culty involving men in SHARE activities,29 we believe 
that there was substantial under-reporting of IPV 
perpetration. Male under-reporting could be due to a 
social desirability bias and stigma associated with 
disclosing abuse37 or gender diﬀ erences in patterns of 
reporting abusive behaviours.21 As in the SASA! trial,40 
the discrepancy between reports of sexual violence 
between men and women were larger than were those of 
physical violence, possibly due to social norms condoning 
physical male disciplinary violence in Uganda.21,41 Marital 
rape (ie, forced sex) is not illegal in Uganda and choices 
about when to have sex are considered to be a man’s 
prerogative.42 Therefore, men might have under-reported 
sexual violence because they did not perceive it to be 
abuse. For these reasons, we considered women’s 
accounts of IPV to be the more reliable outcomes.
The intervention was associated with a lower HIV 
incidence in the intervention group (aIRR 0·67 [95% CI 
0·46–0·97]), which was more pronounced in men (0·59 
[0·35–0·95]) than in women (0·72 [0·49–1·07]). Although 
Control Intervention PRR (95% CI) aPRR* (95% CI)
Women
>1 sexual partners in past year
Follow-up 1 214/2426 (9%) 201/2341 (9%) 1·00 (0·98–1·01) 1·00 (0·98–1·01)
Follow-up 2 207/2127 (10%) 157/1812 (9%) 0·99 (0·97–1·01) 0·98 (0·97–1·00)
Non-marital sex partners in past year
Follow-up 1 377/2224 (17%) 367/2127 (17%) 1·02 (0·89–1·16) 1·01 (0·90–1·15)
Follow-up 2 396/2006 (20%) 306/1693 (18%) 0·92 (0·80–1·05) 0·89 (0·78–1·01)
Alcohol use with sex in past year 
Follow-up 1 647/2426 (27%) 620/2342 (27%) 0·99 (0·90–1·09) 0·99 (0·91–1·09)
Follow-up 2 435/2127 (21%) 361/1812 (20%) 0·97 (0·86–1·10) 0·96 (0·85–1·09)
Condom use in past year
Follow-up 1 201/2362 (9%) 216/2282 (10%) 1·11 (0·93–1·34) 1·12 (0·95–1·33)
Follow-up 2 192/1170 (16%) 157/931 (17%) 1·03 (0·85–1·25) 1·01 (0·84–1·21)
Partner’s disclosure of HIV status in past year
Follow-up 1  497/2340 (21%) 492/2257 (22%) 1·03 (0·92–1·15) 1·03 (0·92–1·15)
Follow-up 2 455/2037 (22%) 457/1740 (26%) 1·18 ( 1·05–1·32) 1·18 ( 1·06–1·32)
Self-disclosure of HIV status to partner in past year
Follow-up 1  874/2339 (37%) 880/2257 (39%) 1·04 (0·97–1·12) 1·05 (0·97–1·12)
Follow-up 2 752/2036 (37%) 731/1740 (42%) 1·14 (1·05–1·23) 1·15 (1·06–1·24)
Men
>1 sexual partners in past year
Follow-up 1 829/1612 (51%) 668/1406 (48%) 0·92 (0·90–0·99) 0·96 (0·90–1·03)
Follow-up 2 676/1437 (47%) 538/1150 (47%) 0·99 (0·91–1·08) 1·02 (0·94–1·10)
Non-marital sex partners in past year
Follow-up 1 804/1641 (49%) 642/1433 (45%) 0·91 (0·85–0·99) 0·95 (0·89–1·02)
Follow-up 2 645/1437 (45%) 495/1150 (43%) 0·96 (0·88–1·05) 0·98 (0·90–1·06)
Alcohol use with sex (past year)
Follow-up 1 787/1612 (49%) 697/1406 (50%) 1·02 (0·94–1·09) 1·03 (0·97–1·09)
Follow-up 2 670/1437 (47%) 525/1150 (46%) 0·98 (0·90–1·06) 0·98 (0·91–1·05)
Condom use in past year
Follow-up 1 217/1613 (14%) 216/1408 (15%) 1·14 (0·96–1·36) 1·06 (0·90–1·24)
Follow-up 2 188/806 (23%) 153/601 (26%) 1·09 (0·91–1·31) 1·04 (0·87–1·24)
Partner’s disclosure of HIV status in past year
Follow-up 1 425/1607 (27%) 372/1374 (27%) 1·02 (0·91–1·15) 1·09 (0·97–1·22)
Follow-up 2 401/1409 (29%) 385/1107 (35%) 1·22 (1·09–1·37) 1·24 (1·11–1·39)
Self-disclosure of HIV status to partner in past year
Follow-up 1 549/1607 (34%) 494/1374 (36%) 1·05 (0·95–1·16) 1·10 (1·00–1·21)
Follow-up 2 444/1409 (32%) 404/1107 (37%) 1·16 (1·04–1·29) 1·17 (1·05–1·31)
All data are n/number who responded (%), unless otherwise indicated. PRR=prevalence rate ratio. aPRR=adjusted 
prevalence rate ratio. *Eﬀ ects of intervention adjusted for baseline age, baseline education, baseline marital status and 
baseline number of non-marital sex partners. Each outcome was also adjusted for its baseline measure.
Table 3: Eﬀ ect of intervention on risk behaviours and HIV disclosure
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we cannot identify the speciﬁ c cause of these reductions, 
decreases in forced sex and increases in HIV disclosure 
might have contributed to reductions in HIV incidence 
in the intervention group.
There is a plausible biological explanation for a causal 
association between decreases in forced sex and falls in 
HIV infection in women. Forced, penetrative sex might 
induce a traumatic inﬂ ammatory response that recruits 
target cells to the vaginal or cervical site of injury3,43 and 
disrupts the integrity of the epithelial barrier, increasing 
susceptibility to HIV.3 However, the small number of 
women reporting forced sex in our study suggests that the 
reductions in forced sex would have only had a slight eﬀ ect 
on female HIV incidence. Women who experience IPV 
might also have heightened susceptibility to HIV infection 
due to a clustering of their own risk behaviours and those 
of their violent male partner. Unmeasured behaviours of 
women (eg, anal sex, commercial sex work) and their male 
partners (eg, substance use, undisclosed sexual assault on 
partners and non-partners) might account for the 
decreases of HIV incidence in our study. Thus, although 
interpretation of the mechanisms by which reductions in 
IPV might have contributed to diﬀ erences in HIV 
incidence is problematic, our results are supported by an 
observational study20 from Rakai that estimated that the 
adjusted population fraction of HIV attributable to IPV 
(emotional, physical, and sexual) was 22%.
The intervention was also associated with signiﬁ cantly 
increased rates of self-disclosure and partner-disclosure of 
HIV results, which might have contributed to diﬀ erences 
in HIV incidence. Increased disclosure suggests a rise in 
communication between partners and improved 
discussion and implementation of HIV risk reduction. 
Disclosure might have motivated more men and women, 
particularly in the intervention group, to seek HIV testing 
or access medical care, including HAART.
This trial coincided with the introduction of HAART 
and a HIV prevention trial that circumcised men.33 The 
use of HAART was higher in women than in men at 
baseline, which might have contributed to lower rates of 
new infections in men, but HAART was equitably 
provided to all participants and so availability of treatment 
Control Intervention Comparisons
Incident cases
(person-years)
Participants* Incident 
cases per 100 
person-years
Incident cases
(person-years)
Participants* Incident 
cases per 100 
person-years
IRR (95% CI); 
p value
aIRR† (95% CI); 
p value
Women 71 (6154) 2038 1·15 56 (5649) 1925 0·99 0·86 (0·61–1·22); 
p=0·396
0·72 (0·49–1·07); 
p=0·1020
Men 48 (4237) 1435 1·13 27 (3861) 1326 0·70 0·62 (0·39–0·99); 
p=0·045
0·59 (0·35–0·95); 
p=0·0304
Overall 119 (10 390) 3473 1·15 83 (9510) 3251 0·87 0·76 (0·58–1·01); 
p=0·057
0·67 (0·46–0·97); 
p=0·0362
IRR=incidence rate ratio. aIRR=adjusted incidence rate ratio.*Participants who contributed to the person-year calculation. †Adjusted for baseline HIV prevalence by trial 
group, baseline age, baseline education, baseline marital status, and circumcision status of men or primary male partner of female respondents.
Table 4: Incidence of HIV by study group
 Panel 3: Research in context
Systematic review
In January, 2004, we searched PubMed, Scopus, and PsycINFO for English-language 
systematic reviews and randomised controlled trials of community-based interventions 
to reduce intimate partner violence (IPV) and HIV infection. We used a combination of 
text terms and subject headings, and open-ended search dates, but did not identify any 
reviews or trials on integrated IPV and HIV reduction eﬀ orts. A 2000 review paper 
recommended that HIV prevention programmes integrate multidisciplinary approaches 
to account for the role that violence has in women’s lives.5 In response, we used a public 
health process to integrate the Safe Homes and Respect for Everyone (SHARE) violence 
reduction intervention into Rakai Health Sciences Program’s (RHSP) existing HIV services 
in Uganda.29 With data from the Rakai Community Cohort Study, we estimated the 
prevalence, determinants, and correlates of IPV and HIV infection. Next, we chose two 
prevention approaches adapted to meet the needs of the population. We chose the 
Resource Guide for Mobilising Communities to Prevent Domestic Violence31 and 
Stepping Stones38 because both were developed for use in rural Africa and had been 
implemented in Uganda; both were community-based, developed for sustainability, and 
focused on change at multiple levels; and together they included strategies to address 
IPV, gender norms and inequalities, HIV, communication and relationship skills among 
adults and adolescents. We also used recommendations5 to add procedures to RHSP’s 
HIV counselling and testing programmes to identify and assist women at risk of IPV. 
Reviews done in 201014 and 201339 examined interventions addressing HIV and IPV 
globally and in sub-Saharan Africa. Both highlighted the promise multifaceted 
community-based interventions hold for improving women’s health and empowerment, 
but noted that although some previous interventions have reduced IPV, none have 
shown a decrease in HIV infection.14,39
Interpretation
SHARE is the ﬁ rst study of behavioural interventions to show signiﬁ cant decreases in both 
IPV and HIV incidence. As for Stepping Stones,16 IMAGE,18 and SASA!,19 SHARE was 
multifaceted and done at the population-level. Uniquely, SHARE was nested within the 
infrastructure of an existing HIV research and service provision organisation. The SHARE 
intervention model could inform other HIV programmes’ eﬀ orts to address IPV and HIV 
simultaneously, and its approach could be adopted, at least partly, as a standard of care 
for other HIV programmes in sub-Saharan Africa. HIV counselling and testing provides an 
opportunity to screen for and address IPV and counsellors could mitigate important 
contextual risks factors for HIV transmission that are associated with experiences of 
violence. We also recommend5 that HIV counselling and testing services consider the 
needs of violence survivors and oﬀ er risk reduction counselling and disclosure support in 
the context of women’s risk of abuse.
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should not have biased incidence between study groups. 
Although circumcision reduces male HIV acquisition,33,44 
it is unlikely to account for diﬀ erences in rates for HIV 
acquisition in men between study groups since 
circumcision prevalence was similar at baseline and we 
controlled for circumcision status at follow-up.
Our trial has several limitations. Cluster randomisation 
was based on a randomisation scheme designed for a 
previous family planning cluster-randomised trial and 
due to ﬁ nancial constraints, we could only introduce the 
intervention into four of the 11 clusters, leading to an 
imbalance in numbers and poor comparability for some 
variables at baseline. However, adjustment for the 
covariates that diﬀ ered at baseline probably minimised 
confounding. Additionally, the previous family planning 
intervention increased hormonal contraceptive use and 
decreased the pregnancy rate, but had no eﬀ ect on 
condom use,28 and thus probably had little to no eﬀ ect on 
the results of our study. The retention rate (75% at either 
follow-up visit) was low and diﬀ ered between groups and 
so it is possible that selective losses to follow-up might 
have aﬀ ected trial results; higher-risk individuals were 
more likely to discontinue than were those at a lower risk 
(data not shown). Additionally, retention rates were 
somewhat higher in the control than in the intervention 
group (ﬁ gure 2) so selective loss to follow-up of higher-
risk individuals in the intervention group might have 
diﬀ erentially reduced HIV incidence.
Intervention group participants might have been more 
motivated to report lower IPV than were those in the 
control group due to a social desirability bias. However, a 
meta-analysis suggested low to moderate correlation 
between self-reports of IPV and validated scores of social 
desirability.45 Although contamination between groups 
could have occurred (eg, by police or community services 
whose jurisdictions covered both areas), we believe it is 
unlikely because RCCS clusters are geographically 
separated and any contamination would bias results 
towards the null.
As noted in other studies in Africa,46 reports of self-
disclosure of HIV status were higher than were reports 
of partner-disclosure in both men and women, which 
might be due to a social desirability bias. Alternatively, 
respondents who were HIV-infected and in violent 
relationships might have feared to share their results 
with a partner, but falsely claim that they did so.46 Self-
reports of HIV status disclosure might be potentially of 
questionable reliability, but reports of partner disclosure 
signiﬁ cantly increased in both men and women with 
exposure to SHARE, and might have contributed to 
diﬀ erences in HIV incidence.
We did not obtain data for the frequency or severity of 
IPV. Thus, we were not able to distinguish repeated 
abuse from isolated events, and severe and moderate 
forms of violence from minor abuse. We recommend 
that future research assess the severity and frequency of 
violence. As noted, we also did not measure all sexual 
risk behaviours that are potential pathways between IPV 
and HIV infection and thus we do not know how they 
might have contributed to decreases in HIV incidence.
In conclusion, exposure to SHARE was associated with 
signiﬁ cant decreases in both intimate partner violence 
and HIV incidence in Rakai. These ﬁ ndings hold great 
potential for HIV programmes and should inform future 
work toward universal targets for HIV prevention, 
treatment, and care. We believe our ﬁ ndings can be 
extended to other settings in sub-Saharan Africa and as 
countries in the region are scaling up combination HIV 
prevention and interventions to eliminate mother-to-
child transmission of HIV, stakeholders should consider 
the potential use of investigating IPV prevention into 
HIV counselling and testing, treatment, and care 
services. The SHARE community mobilisation approach 
is a potential model that countries can incorporate into 
their national programmes and we recommend that it be 
replicated and rigorously assessed through longitudinal 
research to investigate its eﬀ ect in other settings. It is 
also important to establish which risk behaviours 
mediate the relation between IPV and HIV infection. 
Finally, as international initiatives emphasise the 
importance of health strategies that promote gender 
equality and prioritise the needs of women and girls, this 
study’s ﬁ ndings suggest that the SHARE model is a 
promising, gender-responsive intervention to reduce 
both IPV against women and infection with HIV.
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